JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

ZJYL · NASDAQ · Healthcare / Medical Instruments & Supplies

3.50USD-0.37 (-9.56%)

Price History

Full chart

Market Stats

Previous Close3.87

Open3.83

Day Range3.40 – 3.83

52-Week Range1.53 – 12.00

Volume18.79K

Market Cap142.61M

P/E (TTM)9.55

Forward P/E0.00

EPS0.20

Dividend Yield0.00%

Beta7.33

50-Day Avg2.34

200-Day Avg2.62

About

Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. It operates in the Mainland China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. operates as a subsidiary of Jolly Harmony Enterprises Limited.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOMr. Erqi Wang
Employees273
HeadquartersNo. 33 Lingxiang Road, Changzhou, China, USA
Websitehttps://www.zhjmedical.com

Leadership

Mr. Erqi WangChairman of the Board, President & CEO · b. 1970
Mr. Ziqiang WangCFO & Director · b. 1971

Financials

Income Statement

Currency: USD	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Revenue	20.91M	20.37M	16.19M	20.76M	19.19M	19.82M	23.50M	20.69M
Growth (%)	-	-2.61%	-20.49%	+28.22%	-7.58%	+3.29%	+18.57%	-11.98%
Cost of Revenue	13.25M	12.86M	10.70M	14.40M	12.99M	13.04M	14.00M	14.64M
Gross Profit	7.66M	7.51M	5.50M	6.36M	6.20M	6.78M	9.50M	6.04M
Gross Margin	36.62%	36.88%	33.95%	30.64%	32.30%	34.23%	40.43%	29.22%
Operating Expense	3.43M	3.11M	3.14M	3.73M	4.07M	3.92M	5.86M	5.44M
Operating Income	4.23M	4.40M	2.35M	2.63M	2.13M	2.87M	3.64M	608.18K
Operating Margin	20.22%	21.62%	14.54%	12.67%	11.10%	14.47%	15.48%	2.94%
EBITDA	4.60M	4.75M	2.79M	3.23M	3.10M	3.09M	3.98M	932.87K
EBITDA Margin	21.98%	23.31%	17.23%	15.56%	16.15%	15.61%	16.96%	4.51%
Net Income	3.68M	3.65M	2.21M	2.63M	2.71M	2.88M	3.68M	1.19M
Net Income Margin	17.61%	17.91%	13.62%	12.67%	14.10%	14.52%	15.64%	5.76%
R&D	1.20M	1.13M	1.26M	1.57M	1.89M	1.54M	1.50M	1.56M
R&D as % of Total Revenue	5.75%	5.55%	7.79%	7.55%	9.86%	7.78%	6.37%	7.53%
Interest Expense	-	22.85K	112.40K	9.49K	-	-	-	-
Interest Expense % of Total Revenue	-	0.11%	0.69%	0.05%	-	-	-	-

Balance Sheet

Currency: USD	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Assets	18.68M	20.36M	20.82M	21.90M	20.94M	32.90M	45.80M	53.37M
Total Liabilities	9.68M	9.66M	10.01M	7.87M	5.70M	8.92M	17.25M	23.80M
Total Equity	9.00M	10.71M	10.80M	14.03M	15.24M	23.98M	28.82M	29.64M
Cash	853.30K	1.94M	1.66M	3.67M	4.79M	6.93M	8.14M	7.46M
Total Debt	712.53K	2.87M	2.65M	-	-	-	11.60M	18.91M
Net Debt	-140.77K	929.86K	983.72K	-3.67M	-4.79M	-	3.47M	11.45M

Cash Flow

Currency: USD	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Operating Cash Flow	-2.39M	-1.33M	2.50M	5.84M	1.58M	3.11M	-1.21M	2.90M
Investing Cash Flow	1.96M	126.94K	-1.96M	-1.07M	-120.90K	-	-9.51M	-10.79M
Financing Cash Flow	-3.19M	2.36M	-343.91K	-2.87M	121.86K	6.91M	11.65M	7.35M
Capital Expenditure	187.68K	73.33K	142.32K	42.88K	40.17K	113.94K	1.12M	6.63M
Free Cash Flow	-2.58M	-1.40M	2.36M	5.80M	1.54M	2.99M	-2.33M	-3.73M
FCF to OCF	107.84%	105.53%	94.31%	99.27%	97.46%	96.33%	193.12%	-128.33%

Earnings

Report Date	Sep 24, 2021	Dec 10, 2021	Dec 20, 2022	Mar 21, 2023	Jan 24, 2025	Aug 20, 2025	Jan 23, 2026
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	-
EPS Actual	0.28	0.23	0.15	0.34	0.01	0.00	0.01
Surprise	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	After-hours

Key Statistics & Ratios

Market Cap142.61M

Enterprise Value141.62M

Trailing P/E9.55

Forward P/E0.00

Price / Sales7.23

Price / Book4.91

EPS0.20

Book Value3.87

Revenue (TTM)19.73M

Gross Profit (TTM)6.17M

EBITDA657.35K

Profit Margin5.95%

Operating Margin-7.23%

Return on Equity4.02%

Return on Assets0.50%

Shares Outstanding73.66M

Shares Float64.84M

Beta7.33

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Ownership Breakdown

Institutions: 0.03%
Insiders: 11.97%
Retail / Other: 88.00%

Top Institutional Holders

Advisor Group Holdings, Inc.
3.10K0.00%
UBS Group AG
1.22K0.00%
Mercer Global Advisors Inc.
10.00%
Bell Investment Advisors, Inc
00.00%
Renaissance Technologies Corp
00.00%
Morgan Stanley - Brokerage Accounts
00.00%
Jane Street Group LLC
00.00%
Geode Capital Management, LLC
00.00%
XTX Topco Ltd
00.00%
TWO SIGMA SECURITIES, LLC
00.00%
Citadel Advisors Llc
00.00%

Top Fund Holders

Fidelity Nasdaq Composite Index
5.33K0.07%

Stock Splits

Mar 16, 20261:20
Feb 8, 202420:1